General Gynecology | Page 6 of 14 | Links Medicus Content Curation & Alerts in Medicine

FREE: Screening for High-Risk Human Papillomavirus Using Passive, Self-Collected Menstrual Blood #obgyn #HPV #GYN https://t.co/zLno2ab605 pic.twitter.com/mfPGjlTLdD

— The Green Journal (@greenjrnl) September 1, 2022

Systematic Review | Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine‐device use.

2 Sep, 2022 | 13:07h | UTC

Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine‐device use – Cochrane Library

RCT | Placement of an intrauterine device within 48 hours after early medical abortion.

1 Sep, 2022 | 11:51h | UTC

Placement of an intrauterine device within 48 hours after early medical abortion – a randomized controlled trial – American Journal of Obstetrics & Gynecology

A simple cervicovaginal epigenetic test for screening and rapid triage of women with suspected endometrial cancer: validation in several cohort and case/control sets.

29 Aug, 2022 | 11:58h | UTC

A Simple Cervicovaginal Epigenetic Test for Screening and Rapid Triage of Women With Suspected Endometrial Cancer: Validation in Several Cohort and Case/Control Sets – Journal of Clinical Oncology

Commentary on Twitter

Pleased to share our work out today in J Clin Oncol "A Simple Cervicovaginal Epigenetic Test for Screening and Rapid Triage of Women With Suspected Endometrial Cancer …" #FORECEE #CCBIO #H2020 @eveappeal @Gynkreft @medofak_uib @haukeland_no
#screening https://t.co/Av53WSWqoQ pic.twitter.com/dL4j7nW7vt

— Line Bjørge (@DrLB) August 24, 2022

Under a https://creativecommons.org/licenses/by/4.0/ license

RCT | HPV self-sampling among long-term non-attenders to cervical cancer screening.

26 Aug, 2022 | 13:27h | UTC

HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: a pragmatic randomised controlled trial – British Journal of Cancer

Commentary on Twitter

Pragmatic randomised controlled trial of 3 different HPV screening approaches suggests that opt-in and particularlly send-to-all self-sampling increased participation among long-term, higher-risk non-attenders: https://t.co/hBouqoBMnU #GynCSM #hsronc

— NatureRevClinOncol (@NatRevClinOncol) August 25, 2022

Endocervical sampling in women with suspected cervical neoplasia: a systematic review and meta-analysis of diagnostic test accuracy studies.

26 Aug, 2022 | 13:18h | UTC

Endocervical sampling in women with suspected cervical neoplasia: a systematic review and meta-analysis of diagnostic test accuracy studies – American Journal of Obstetrics & Gynecology

Systematic Review | Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.

26 Aug, 2022 | 13:11h | UTC

Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer – Cochrane Library

Summary: Hysterectomy with medical management for cervical cancer that has spread to nearby tissues only – Cochrane Library

A review of more than 2000 cases of site-specific pelvic endometriosis rates by MRI: a guide to minimizing under/overdiagnosis non-invasively.

26 Aug, 2022 | 13:08h | UTC

A review of more than 2000 cases of site-specific pelvic endometriosis rates by MRI: a guide to minimizing under/overdiagnosis non-invasively – Insights into Imaging

Observational study suggests frequent aspirin use may reduce the risk of ovarian cancer.

25 Aug, 2022 | 11:49h | UTC

Modification of the Association Between Frequent Aspirin Use and Ovarian Cancer Risk: A Meta-Analysis Using Individual-Level Data From Two Ovarian Cancer Consortia – Journal of Clinical Oncology (link to abstract – $ for full-text)

Commentaries:

Frequent Aspirin Use Tied to Lower Ovarian Cancer Risk – HealthDay

Frequent Aspirin Use Shows Promise for Preventing Ovarian Cancer in Individuals at Higher Risk – University of Utah

Commentary on Twitter

💊 Frequent aspirin use ⬇️ #OvarianCancer risk among women with other risk factors for ovarian cancer

Read more in #JCO: https://t.co/QV4bK0lB5M #prevention #gyncsm #ovca @LaurenMHurwitz @b_trabert pic.twitter.com/xvU1yb60mi

— Journal of Clinical Oncology (@JCO_ASCO) August 18, 2022

Long-term follow up of a RCT | Precancerous cervical lesions caused by non-vaccine-preventable HPV types after vaccination with the bivalent AS04-adjuvanted HPV vaccine.

24 Aug, 2022 | 13:53h | UTC

Precancerous cervical lesions caused by non-vaccine-preventable HPV types after vaccination with the bivalent AS04-adjuvanted HPV vaccine: an analysis of the long-term follow-up study from the randomised Costa Rica HPV Vaccine Trial – The Lancet Oncology (link to abstract – $ for full-text)

Commentary: Clinical Unmasking May Cause Increased Rates of High-Grade Cervical Neoplasia From Non–Vaccine Preventable HPV – Cancer Network

Commentary on Twitter

Virological replacement & clinical unmasking are two phenomena of interest following #HPVvaccination. We show that clinical unmasking might attenuate long-term reductions in cervical precancer following successful implementation of HPV vax programs in highly screened populations https://t.co/Z7dGQNG1kG

— Monica Sierra (@MonicaSSierra) June 14, 2022